Skip to main content
SpringerLink
Log in

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Iguchi T, et al. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report Drug Safety : 4 Aug 2021. Available from: URL: https://doi.org/10.1007/s40264-021-01104-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan. Reactions Weekly 1868, 6 (2021). https://doi.org/10.1007/s40278-021-00463-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-00463-8

Search

Navigation